Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nextran

Division of Baxter International Inc.

Latest From Nextran

Roslin Bio-Med Ltd.

Can Dolly the sheep bring home the bacon? Roslin Bio-Med has licensed nuclear transfer technology from the Roslin Institute to develop transgenic pigs from which the start-up hopes to obtain organs for transplant and blood products.
BioPharmaceutical

BioTransplant: Turned on to Tolerance

Thousands die each year of end-stage organ failure. Transplantation is the preferred therapy, but there is a chronic shortage of human organs and organ rejection remains a problem. Bringing xenotransplantation to market has become a big company affair, but BioTransplant is a biotech still looking to win a piece of the market through an unusual partnership and unique technology.
BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Baxter International Inc.
  • Senior Management
  • Marvin Miller, Pres. & CEO
    Don Charlton, Controllor
    Rick Epstein, VP, Sales & Mktg.
    John S Logan, PhD, VP, R&D
  • Contact Info
  • Nextran
    Phone: (609) 243-0009
    303 B College Road East
    Princeton, NJ 08540
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register